Texas Capital Bank Wealth Management Services Inc purchased a new stake in Agilent Technologies, Inc. (NYSE:A - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7,937 shares of the medical research company's stock, valued at approximately $1,080,000.
Other hedge funds have also made changes to their positions in the company. Board of the Pension Protection Fund acquired a new stake in Agilent Technologies during the 4th quarter worth about $27,000. Navalign LLC acquired a new stake in Agilent Technologies during the 4th quarter worth about $27,000. Entrust Financial LLC acquired a new stake in Agilent Technologies during the 4th quarter worth about $31,000. Physician Wealth Advisors Inc. boosted its position in Agilent Technologies by 490.0% during the 3rd quarter. Physician Wealth Advisors Inc. now owns 236 shares of the medical research company's stock worth $30,000 after acquiring an additional 196 shares during the period. Finally, Torren Management LLC acquired a new stake in Agilent Technologies during the 4th quarter worth about $32,000.
Key Stories Impacting Agilent Technologies
Here are the key news stories impacting Agilent Technologies this week:
- Positive Sentiment: Agilent posted second-quarter EPS of $1.49, topping estimates, while revenue rose 10% year over year to $1.83 billion, also ahead of forecasts. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
- Positive Sentiment: The company raised its FY 2026 profit outlook, signaling management confidence in continued demand for medical tools, lab research equipment, and diagnostic products. Agilent raises 2026 profit forecast on strong demand for lab tools
- Positive Sentiment: Bank of America upgraded Agilent to Buy, citing strong execution, improving demand trends, and market share gains in key instrument categories. Agilent Technologies shares jump on earnings beat, Bank of America upgrade
- Positive Sentiment: TD Cowen and Barclays also raised price targets, adding to the positive analyst sentiment around the stock after the earnings release. Agilent Technologies Stock Soars On Broad Q2 Beat, Company Stands Out In Tools Sector
- Neutral Sentiment: Some commentary noted that recurring revenue reached 66% of sales, but that the stock had been under pressure earlier despite the earnings beat and higher guidance.
Agilent Technologies Stock Performance
Shares of A opened at $135.79 on Friday. The company's fifty day moving average is $115.45 and its 200-day moving average is $128.71. Agilent Technologies, Inc. has a 12 month low of $108.35 and a 12 month high of $160.27. The firm has a market cap of $38.37 billion, a price-to-earnings ratio of 27.27, a price-to-earnings-growth ratio of 2.44 and a beta of 1.22. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44.
Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.74%. The company had revenue of $1.84 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same quarter in the prior year, the business posted $1.31 EPS. Agilent Technologies's quarterly revenue was up 10.0% on a year-over-year basis. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Equities analysts expect that Agilent Technologies, Inc. will post 5.95 EPS for the current fiscal year.
Agilent Technologies Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.255 per share. The ex-dividend date is Tuesday, June 30th. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. Agilent Technologies's dividend payout ratio is 22.52%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on A shares. Wells Fargo & Company decreased their price objective on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a research report on Thursday. UBS Group decreased their price objective on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating for the company in a research report on Thursday, February 26th. Bank of America upgraded Agilent Technologies from a "neutral" rating to a "buy" rating and decreased their price objective for the stock from $150.00 to $145.00 in a research report on Thursday. Wall Street Zen lowered Agilent Technologies from a "buy" rating to a "hold" rating in a research report on Saturday, May 9th. Finally, Robert W. Baird raised their price objective on Agilent Technologies from $155.00 to $156.00 and gave the stock an "outperform" rating in a research report on Tuesday. Two investment analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and an average price target of $160.93.
Get Our Latest Stock Analysis on A
Agilent Technologies Company Profile
(
Free Report)
Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.
Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.
"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.